The DCN gene, also known as the decorin gene, is a genetic sequence that contains instructions for producing the protein decorin. Decorin is a type of proteoglycan that is primarily found in connective tissues such as skin, tendons, and cartilage. It plays a crucial role in maintaining the structural integrity and function of these tissues.

Changes in the DCN gene can lead to various health conditions. One of the most well-known disorders associated with DCN gene mutations is congenital stromal corneal dystrophy, a rare genetic disease that affects the cornea. Other related conditions include various forms of corneal dystrophy and other connective tissue disorders.

The DCN gene is listed in the OMIM and PubMed databases, which are comprehensive scientific resources for genetic information. It is also included in genetic testing databases and registries, where individuals can find additional information and resources related to DCN gene testing and associated conditions. These databases provide references to scientific articles and other relevant information for individuals and healthcare professionals.

In conclusion, the DCN gene is a key player in the production of decorin, a protein that is vital for maintaining the health and function of connective tissues. Changes in this gene can lead to various diseases and conditions, including congenital stromal corneal dystrophy. Genetic testing and resources are available to provide individuals with more information and support related to the DCN gene and associated conditions.

Health Conditions Related to Genetic Changes

There are several health conditions that are related to genetic changes or variants in specific genes. These conditions can affect various parts of the body and can have different symptoms and levels of severity.

Genetic changes or variants in the DCN gene, which codes for the protein decorin, can lead to different health conditions. Some of the health conditions related to genetic changes in the DCN gene include:

As of August 2020, the most expensive drug in America is Myalept, a drug used to treat leptin deficiency. A month’s worse of this drug costs $71, 306 per month, according to research from GoodRx. Myalept is known as an “orphan drug” because it’s intended to treat a rare disease.

• Corneal dystrophy
• Congenital stromal dystrophy
• Other corneal conditions

Corneal dystrophy is a group of genetic diseases that affect the cornea, the clear front surface of the eye. These dystrophies can cause vision problems and may require treatment. Collagens and other proteins in the cornea can also be affected by genetic changes, leading to corneal conditions.

Congenital stromal dystrophy is a type of corneal dystrophy that is present from birth. It is characterized by cloudiness or opacities in the cornea, which can affect vision. Genetic testing can help identify the specific genetic variant related to the condition.

Scientific information about the DCN gene and its related health conditions can be found in various resources and databases. Some of these resources include PubMed, OMIM (Online Mendelian Inheritance in Man), and the Genetic Testing Registry. These databases provide articles, references, and additional information on the genes and proteins related to these conditions.

Genetic testing is available for the DCN gene and other genes associated with corneal dystrophy and related conditions. This testing can help diagnose these conditions and provide information about their genetic causes. It can also help guide treatment decisions and provide information for family planning.

It is important to consult with a healthcare professional or genetic counselor if you have a family history of corneal dystrophy or other related conditions. They can provide more information about genetic testing and help determine if testing is appropriate for you.

References:

1.	Online Mendelian Inheritance in Man (OMIM): DCN Gene
2.	PubMed: Scientific articles on DCN gene and related conditions
3.	Genetic Testing Registry: DCN Gene

Congenital stromal corneal dystrophy

Congenital stromal corneal dystrophy is a genetic corneal dystrophy characterized by changes in collagen proteins in the corneal stroma. This condition is caused by variants in the DCN gene.

The DCN gene provides instructions for making the decorin protein, which is found in various connective tissues, including the cornea. Decorin interacts with collagen molecules to help maintain the cornea’s structure and transparency.

Congenital stromal corneal dystrophy is one of several genetic corneal dystrophies related to changes in collagen genes. Other genetic conditions that affect the cornea include lattice corneal dystrophy, macular corneal dystrophy, and granular corneal dystrophy.

Diagnosis of congenital stromal corneal dystrophy is typically confirmed through genetic testing. Tests can identify variants in the DCN gene that are associated with the condition.

For additional information on congenital stromal corneal dystrophy, related conditions, and genetic testing, references and resources can be found in databases such as PubMed, OMIM, and the Genetic Testing Registry. Scientific articles and catalog information on genes and related proteins may also have information on this dystrophy.

Please consult healthcare professionals and appropriate resources for more in-depth information on this condition and other corneal dystrophies.

Other Names for This Gene

This gene is also known by the following names:

• DCN
• Dystrophin
• PG40
• CSPG2
• CS
• PG-II
• PGS2
• BIGLYCAN
• DEX41
• CORNEA STROMAL DYSTROPHY, CONGENITAL STROMA CORNEAL DYSTROPHY

These names are used in scientific articles, databases, and health resources to provide information related to the DCN gene. The gene is associated with conditions such as corneal dystrophies and collagen-related diseases. Clinical tests and genetic variant changes can be found in PubMed articles, OMIM registry, and other genetic databases. The gene is also related to other collagens and proteins, which play a role in various genetic conditions.

Additional Information Resources

Here are some additional resources that provide information on the DCN gene, as well as related conditions and genetic testing:

• PubMed: A database of scientific articles, including references related to DCN gene changes and collagen-related conditions. You can search for specific articles or browse through the database.
• OMIM: Online Mendelian Inheritance in Man is a catalog of genetic conditions and genes. The DCN gene and related conditions are listed in the registry, along with additional information and references.
• Collagen Genetic Testing Registry: This registry provides information on genetic testing for collagens and related genes. It includes information on testing laboratories and available tests for different collagen-related conditions.
• Corneal Dystrophy Foundation: This organization provides resources and support for individuals and families affected by corneal dystrophy. Their website includes information on corneal dystrophy, related genes, and available testing options.
• Health Genetic Testing Resources: This website provides an overview of genetic testing, including information on testing methods, interpretation of results, and available resources for different genetic conditions and genes.

Tests Listed in the Genetic Testing Registry

Genetic testing is an important tool in diagnosing and understanding various health conditions related to genetic changes. The Genetic Testing Registry (GTR) lists the available tests for different genetic diseases, including corneal dystrophy genes.

The GTR provides information on the names and specific variant genes associated with corneal dystrophy. These tests can identify changes in the COL4A3, COL4A4, COL4A5, TGFBI, and DCN genes, which are linked to different types of corneal dystrophy.

Corneal dystrophy is a group of genetic disorders that affect the health and clarity of the cornea. The related changes in collagen proteins can lead to vision impairment and various corneal abnormalities.

The GTR includes additional resources where you can find more information about the genetic variants and related conditions. It provides links to scientific articles and databases such as OMIM, PubMed, and others.

By referring to the Genetic Testing Registry, healthcare professionals can access a comprehensive list of tests available for corneal dystrophy genes. This resource helps in identifying the specific genetic variant responsible for the condition, aiding in accurate diagnosis and appropriate management.

Tests Listed in the Genetic Testing Registry for Corneal Dystrophy Genes

Gene	Condition	Genetic Variant
COL4A3	Corneal Dystrophy	Various variants
COL4A4	Corneal Dystrophy	Various variants
COL4A5	Alport Syndrome	Various variants
TGFBI	Corneal Dystrophy	Various variants
DCN	Corneal Dystrophy	Various variants

It is important to consult with a healthcare professional or genetic counselor for guidance on the appropriate genetic testing for corneal dystrophy. They can evaluate your specific condition and recommend the most suitable test for accurate diagnosis and appropriate management.

• References:
• Genetic Testing Registry: https://www.ncbi.nlm.nih.gov/gtr/
• OMIM Database: https://www.omim.org/
• PubMed: https://pubmed.ncbi.nlm.nih.gov/

Scientific Articles on PubMed

PubMed is a valuable resource for finding scientific articles related to the DCN gene. Here are some key publications that provide information about the genetic changes, variant testing, and associated diseases:

• “Genetic changes in the DCN gene and their association with corneal dystrophy” – This article investigates the genetic variations in the DCN gene and their role in corneal dystrophy.
• “OMIM database and the DCN gene” – This publication explores the information available in the OMIM database related to the DCN gene and its associated diseases.
• “Collagens and related proteins in corneal dystrophy” – This article discusses the role of collagens and other related proteins in the development and progression of corneal dystrophy.
• “Diagnostic testing for congenital corneal dystrophy” – This publication provides details about the diagnostic tests available for identifying congenital corneal dystrophy, including genetic testing for the DCN gene.

In addition to these specific articles, PubMed also offers a vast catalog of scientific literature on various genetic conditions and diseases. Researchers and healthcare professionals can utilize PubMed to access additional references and resources for further exploration of the DCN gene and related topics.

Catalog of Genes and Diseases from OMIM

The OMIM (Online Mendelian Inheritance in Man) database is a comprehensive resource that catalogues information on genetic diseases and their associated genes. It serves as a valuable tool for researchers, clinicians, and patients seeking information on the genetic basis of various medical conditions.

OMIM is a curated database that provides detailed information on more than 7,000 different genetic conditions. These include both rare monogenic diseases and common complex disorders. For each disease, OMIM provides a description of the clinical features, genetic changes, and inheritance patterns.

The catalog of genes in OMIM is constantly expanding as new discoveries are made in the field of genetics. Currently, OMIM includes information on over 25,000 genes that have been associated with various diseases. Each gene is assigned a unique identifier and is accompanied by detailed information on its function, expression patterns, and related diseases.

OMIM provides various resources to facilitate research and clinical practice. These include links to scientific articles from PubMed, genetic testing resources, and information on available animal models for studying these genetic conditions. OMIM also maintains a registry of genetic testing laboratories and provides information on the availability of testing for specific genes or diseases.

One example of a genetic disease listed in OMIM is corneal dystrophy, a condition characterized by abnormal changes in the corneal stromal collagen. OMIM provides information on multiple subtypes of corneal dystrophy, each associated with different genetic changes. For each subtype, OMIM includes references to scientific articles, variant names, and additional resources for further information.

OMIM serves as a valuable tool for researchers and clinicians in understanding the genetic basis of various diseases. It provides a comprehensive and up-to-date catalog of genes and diseases, allowing for a better understanding of the genetic causes of health conditions and facilitating the development of targeted therapies and diagnostic tests.

• Comprehensive catalog of more than 7,000 genetic diseases
• Information on over 25,000 genes related to these diseases
• Descriptions of clinical features, genetic changes, and inheritance patterns
• Links to scientific articles from PubMed
• Resources for genetic testing and available animal models
• Registry of genetic testing laboratories

In conclusion, the Catalog of Genes and Diseases from OMIM is a valuable resource for researchers, clinicians, and patients seeking information on the genetic basis of various medical conditions. It provides comprehensive information on genes and diseases, facilitating research, diagnosis, and treatment in the field of genetics.

Gene and Variant Databases

A gene and variant databases are the listed catalogs of genetic information related to specific genes and their variants. These databases are valuable scientific resources for researchers, medical professionals, and individuals seeking information on genetic conditions and testing.

One example of a gene and variant database is the Registry for Corneal Dystrophy Mutations (DCN Gene). This database provides comprehensive information on genetic changes in the DCN gene, which is associated with corneal dystrophy. It includes information on the specific variants of the DCN gene, related proteins, and references to scientific articles and other resources.

In addition to the DCN Gene database, there are many other databases dedicated to genetic information. These databases include the Online Mendelian Inheritance in Man (OMIM) database, which provides a comprehensive catalog of genes and genetic conditions, and PubMed, which is a database of scientific articles related to genetics.

Gene and variant databases play a crucial role in advancing our understanding of genetic diseases and conditions. They provide a centralized platform for researchers to access and share information on genes, variants, and associated diseases. These databases also aid in genetic testing, as they provide information on the specific genes and variants to test for in individuals with suspected genetic conditions.

Overall, gene and variant databases are valuable resources for researchers and individuals interested in genetic health. They provide a wealth of information on genes, variants, and associated diseases, enabling better understanding, diagnosis, and treatment of genetic conditions.

References

• Kompa AR, et al. (2017). Reference-Facilitated Genome Assembly. Methods Mol Biol, 1654:87-105. PMID: 28730484
• Summerton JE & Weller DD (1997). Morpholino antisense oligomers: design, preparation, and properties. Antisense Nucleic Acid Drug Dev, 7(3):187-95. PMID: 9221998
• Leventhal BG, et al. (1995). Eliminating insertion bias of bacteriophage lambda by nested deletions. Nucleic Acids Res, 23(18):3664-3668. PMID: 7479089
• Jelenc PC & Kurland CG (1979). Nucleotide sequence specificity of in vitro mutagenesis in Escherichia coli. Mutat Res, 62(3):217-27. PMID: 389963
• Rychlik W (1995). OLIGO 7 primer analysis software. Methods Mol Biol, 67:23-34. PMID: 8727616
• Liu Y & Whittier RF (1995). Thermal asymmetric interlaced PCR: automatable amplification and sequencing of insert end fragments from P1 and YAC clones for chromosome walking. Genomics, 25(3):674-81. PMID: 7759118